ScholarLens Back to search
1998•The American Journal of CardiologyRequires access

Safety of irbesartan in the treatment of mild to moderate systemic hypertension

Teresa A. Simon, R. Thomas Gelarden, Steven A Freitag, Kenneth Kassler-Taub, Richard Davies

Open publisher page 56 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 56 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Irbesartan, Tolerability, Placebo, Adverse effect, Medicine, Internal medicine, Randomized controlled trial, Angiotensin II

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Safety of irbesartan in the treatment of mild to moderate systemic hypertension — Research Paper | ScholarLens